Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing

Jessica L. Mester, Kathleen S. Hruska, Kristen J. Vogel Postula et al.|Journal of Molecular Diagnostics|2019

Cited by 23